POU2F1 Promotes Cell Viability and Tumor Growth in Gastric Cancer through Transcriptional Activation of lncRNA TTC3-AS1

Figure 2

Analysis of differentially expressed genes in metastatic GC tumor samples and primary GC tumor samples. (a) 224 differentially expressed ncRNAs between metastatic tumor samples (n = 21) and primary tumor samples (n = 351) from the HCMD-EXP00440 database; 904 differentially expressed ncRNAs between GC tumor tissues and adjacent normal tissues correlated with GC prognosis; 5 lncRNAs (CATIP-AS2, TTC3-AS1, LINC01993, LINC01564, and LINC02015) upregulated in various cancers involving GC. (b) Cluster analysis of differentially expressed mRNAs using the DAVID database. (c) The correlation between POU2F1 expression and prognosis of GC patients from TCGA database. (d) The correlation between TTC3-AS1 expression and DFS of GC patients from the GEPIA platform. (e) TTC3-AS1 expression in primary tumors with metastasis and primary tumors without metastasis.

(a)

(b)

(c)

(d)

(e)